News & Resources

Intrommune Participates in the Forsyth dentech 2021 Conference

September 22, 2021 Press Releases

Intrommune Therapeutics Appoints Gerard Kugel, D.M.D., M.S., Ph.D. to its Scientific Advisory Board

September 21, 2021 Press Releases

Intrommune Therapeutics Announces Arrival of Stuart Loesch as New CCO

September 8, 2021 Press Releases

Intrommune Therapeutics Launches #PeanutAllergyStrong

August 24, 2021 Press Releases

Intrommune Therapeutics Appoints Moises V. “Moe” Vela, Jr. to its Business Advisory Board

August 20, 2021 Press Releases

Intrommune Therapeutics Appoints Sergi Trilla, MD, MBA to its Scientific and Business Advisory Boards

July 28, 2021 Press Releases

Unicorn Hunters

Corporate Deck

White Paper

Request your copy of our white paper

Videos

Want to learn more about Intrommune and our OMIT technology? Watch the videos below.

The time is now for a desensitization method that is safe, effective and easy to use. This is exactly the solution that Intrommune Therapeutics offers.

Tonya Winders

President, CEO
Allergy & Asthma Network